Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Yen

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Journal of Applied Crystallography|May 2, 2022
Performance of the new biological small- and wide-angle X-ray scattering beamline 13A at the Taiwan Photon SourceO Shih, K-F Liao, Y-Q Yeh, et al.
Science (New York, N.Y.)|April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cellsDan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Nature|July 22, 2014
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Nature|November 19, 2015
Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Science (New York, N.Y.)|April 6, 2013
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiationFang Wang, Jeremy Travins, Byron DeLaBarre, et al.
Blood|June 8, 2017
Enasidenib in mutant <i>IDH2</i> relapsed or refractory acute myeloid leukemiaEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.
Blood|December 5, 2018
Molecular remission and response patterns in patients with mutant-<i>IDH2</i> acute myeloid leukemia treated with enasidenibEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.
Blood|December 17, 2019
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemiaGail J Roboz, Courtney D DiNardo, Eytan M Stein, et al.
Genes & Development|March 5, 2014
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in miceEsra A Akbay, Javid Moslehi, Camilla L Christensen, et al.
Cancer Cell|July 19, 2016
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2Satoshi Inoue, Wanda Y Li, Alan Tseng, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Journal of Applied Crystallography|May 2, 2022
Performance of the new biological small- and wide-angle X-ray scattering beamline 13A at the Taiwan Photon SourceO Shih, K-F Liao, Y-Q Yeh, et al.
Science (New York, N.Y.)|April 6, 2013
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cellsDan Rohle, Janeta Popovici-Muller, Nicolaos Palaskas, et al.
Nature|July 22, 2014
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Nature|November 19, 2015
Corrigendum: Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancerSupriya K Saha, Christine A Parachoniak, Krishna S Ghanta, et al.
Science (New York, N.Y.)|April 6, 2013
Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiationFang Wang, Jeremy Travins, Byron DeLaBarre, et al.
Blood|June 8, 2017
Enasidenib in mutant <i>IDH2</i> relapsed or refractory acute myeloid leukemiaEytan M Stein, Courtney D DiNardo, Daniel A Pollyea, et al.
Blood|December 5, 2018
Molecular remission and response patterns in patients with mutant-<i>IDH2</i> acute myeloid leukemia treated with enasidenibEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.
Blood|December 17, 2019
Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemiaGail J Roboz, Courtney D DiNardo, Eytan M Stein, et al.
Genes & Development|March 5, 2014
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in miceEsra A Akbay, Javid Moslehi, Camilla L Christensen, et al.
Cancer Cell|July 19, 2016
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2Satoshi Inoue, Wanda Y Li, Alan Tseng, et al.
Pageof 10